These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 16327976

  • 1. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
    Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH, Galle PR.
    Int J Oncol; 2006 Jan; 28(1):25-32. PubMed ID: 16327976
    [Abstract] [Full Text] [Related]

  • 2. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, Galle PR.
    BMC Cancer; 2006 Oct 02; 6():232. PubMed ID: 17014711
    [Abstract] [Full Text] [Related]

  • 3. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
    Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V.
    J Hepatol; 2006 Jan 02; 44(1):151-7. PubMed ID: 16289418
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis.
    Chetoui N, Sylla K, Gagnon-Houde JV, Alcaide-Loridan C, Charron D, Al-Daccak R, Aoudjit F.
    Mol Cancer Res; 2008 Jan 02; 6(1):42-52. PubMed ID: 18234961
    [Abstract] [Full Text] [Related]

  • 5. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun 02; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 6. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.
    Acta Pharmacol Sin; 2008 Dec 02; 29(12):1467-77. PubMed ID: 19026166
    [Abstract] [Full Text] [Related]

  • 7. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
    Perugorria MJ, Castillo J, Latasa MU, Goñi S, Segura V, Sangro B, Prieto J, Avila MA, Berasain C.
    Cancer Res; 2009 Feb 15; 69(4):1358-67. PubMed ID: 19190340
    [Abstract] [Full Text] [Related]

  • 8. GM-CSF rescues TF-1 cells from growth factor withdrawal-induced, but not differentiation-induced apoptosis: the role of BCL-2 and MCL-1.
    Klampfer L, Zhang J, Nimer SD.
    Cytokine; 1999 Nov 15; 11(11):849-55. PubMed ID: 10547272
    [Abstract] [Full Text] [Related]

  • 9. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
    Lin SJ, Chang C, Ng AK, Wang SH, Li JJ, Hu CP.
    Apoptosis; 2007 Sep 15; 12(9):1659-70. PubMed ID: 17624592
    [Abstract] [Full Text] [Related]

  • 10. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
    Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, Kannan S, Pathak KA, Choudhary M, Teni TR.
    J Pathol; 2009 Feb 15; 217(3):398-407. PubMed ID: 19009587
    [Abstract] [Full Text] [Related]

  • 11. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S, Srivastava RK.
    Int J Oncol; 2007 Apr 15; 30(4):905-18. PubMed ID: 17332930
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 15; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 13. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway.
    Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, Huang CY, Chou CK.
    Oncogene; 2007 Jun 21; 26(29):4272-83. PubMed ID: 17237822
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM.
    Cancer Res; 2009 Feb 01; 69(3):1135-42. PubMed ID: 19155302
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion.
    Xie Z, Choong PF, Poon LF, Zhou J, Khng J, Jasinghe VJ, Palaniyandi S, Chen CS.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):949-57. PubMed ID: 18259754
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF, Yeh PY, Yeh KH, Lu YS, Huang SY, Cheng AL.
    Cancer Res; 2008 Aug 15; 68(16):6698-707. PubMed ID: 18701494
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB, Chen K, Wang CJ, Zheng JW, Yu Y, Peng ZH, Wu ZD.
    Hepatobiliary Pancreat Dis Int; 2008 Oct 15; 7(5):509-14. PubMed ID: 18842498
    [Abstract] [Full Text] [Related]

  • 18. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
    Chang CS, Huang SM, Lin HH, Wu CC, Wang CJ.
    Hepatogastroenterology; 2007 Oct 15; 54(79):2061-8. PubMed ID: 18251160
    [Abstract] [Full Text] [Related]

  • 19. Pleiotropic effects of PI-3' kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis.
    Alexia C, Bras M, Fallot G, Vadrot N, Daniel F, Lasfer M, Tamouza H, Groyer A.
    Ann N Y Acad Sci; 2006 Dec 15; 1090():1-17. PubMed ID: 17384242
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma.
    Kern MA, Haugg AM, Koch AF, Schilling T, Breuhahn K, Walczak H, Fleischer B, Trautwein C, Michalski C, Schulze-Bergkamen H, Friess H, Stremmel W, Krammer PH, Schirmacher P, Müller M.
    Cancer Res; 2006 Jul 15; 66(14):7059-66. PubMed ID: 16849551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.